Back to RPRX Stock Lookup

Royalty Pharma plc (RPRX) – Company Press Releases

Nov 29, 2021 04:15 PM Royalty Pharma to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
Nov 29, 2021 04:15 PM Royalty Pharma to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
Nov 22, 2021 07:10 AM Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
Nov 22, 2021 07:10 AM Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals
Nov 10, 2021 07:00 AM Royalty Pharma Reports Third Quarter 2021 Results
Nov 10, 2021 07:00 AM Royalty Pharma Reports Third Quarter 2021 Results
Oct 18, 2021 09:00 AM Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021
Oct 18, 2021 09:00 AM Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021
Oct 15, 2021 09:00 AM Royalty Pharma Declares Fourth-Quarter 2021 Dividend
Oct 15, 2021 09:00 AM Royalty Pharma Declares Fourth-Quarter 2021 Dividend
Oct 7, 2021 09:00 AM Cibus Appoints Co-Founder Rory Riggs, as Chief Executive Officer
Sep 9, 2021 04:00 AM Avillion announces positive results in MANDALA and DENALI Phase III trials of AstraZeneca's PT027, a fixed-dose combination of albuterol and budesonide, demonstrating significant benefits for asthma p
Sep 3, 2021 09:00 AM Royalty Pharma to Present at Upcoming Investor Conferences
Sep 3, 2021 09:00 AM Royalty Pharma to Present at Upcoming Investor Conferences
Aug 11, 2021 07:00 AM Royalty Pharma Reports Second Quarter 2021 Results
Aug 11, 2021 07:00 AM Royalty Pharma Reports Second Quarter 2021 Results
Jul 19, 2021 09:00 AM Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021
Jul 19, 2021 09:00 AM Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021
Jul 16, 2021 01:45 PM MorphoSys Concludes a US $100 Million Capital Increase to Implement the Purchase of 1,337,552 shares by Royalty Pharma
Jul 16, 2021 09:00 AM Royalty Pharma Declares Third-Quarter 2021 Dividend
Jul 16, 2021 09:00 AM Royalty Pharma Declares Third-Quarter 2021 Dividend
Jul 15, 2021 04:54 PM Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond
Jul 15, 2021 04:54 PM Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond
Jun 7, 2021 09:00 AM Royalty Pharma to Present at Upcoming Investor Conferences
Jun 7, 2021 09:00 AM Royalty Pharma to Present at Upcoming Investor Conferences
Jun 2, 2021 07:45 AM MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma
Jun 2, 2021 07:40 AM Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
Jun 2, 2021 07:40 AM Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
Jun 2, 2021 07:25 AM MorphoSys to Acquire Constellation Pharmaceuticals
May 11, 2021 07:00 AM Royalty Pharma Reports First Quarter 2021 Results
May 11, 2021 07:00 AM Royalty Pharma Reports First Quarter 2021 Results
May 7, 2021 09:00 AM Royalty Pharma to Present at Upcoming Investor Conferences
May 7, 2021 09:00 AM Royalty Pharma to Present at Upcoming Investor Conferences
Apr 21, 2021 04:15 PM Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021
Apr 21, 2021 04:15 PM Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021
Apr 21, 2021 08:10 AM Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes
Apr 21, 2021 08:10 AM Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes
Apr 21, 2021 08:00 AM MSCI Announces Strategic Alliance With Royalty Pharma to Launch Life Sciences Indexes
Apr 15, 2021 09:00 AM Royalty Pharma Declares Second-Quarter 2021 Dividend
Apr 15, 2021 09:00 AM Royalty Pharma Declares Second-Quarter 2021 Dividend
Apr 8, 2021 07:40 AM Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
Apr 8, 2021 07:40 AM Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
Apr 8, 2021 07:30 AM Dicerna Sells OXLUMO™ (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million
Apr 1, 2021 07:30 AM Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK
Apr 1, 2021 07:30 AM Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK
Mar 30, 2021 08:00 AM Royalty Pharma Appoints Henry A. Fernandez as Lead Independent Director
Mar 30, 2021 08:00 AM Royalty Pharma Appoints Henry A. Fernandez as Lead Independent Director
Feb 17, 2021 07:00 AM Royalty Pharma Reports Q4 2020 and Full-Year Results
Feb 17, 2021 07:00 AM Royalty Pharma Reports Q4 2020 and Full-Year Results
Jan 22, 2021 08:00 AM Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021

Back to RPRX Stock Lookup